Xanphyl 100 Capsule contains Acebrophylline 100 mg, a bronchodilator and mucolytic agent primarily used in the management of respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and bronchitis. Acebrophylline acts by relaxing the smooth muscles of the airways, thereby facilitating bronchodilation and improving airflow. Additionally, it exhibits mucoregulatory properties that help reduce mucus viscosity, promoting easier expectoration and enhancing respiratory function. This dual action contributes to symptomatic relief from breathlessness, wheezing, and cough associated with obstructive airway diseases. Xanphyl 100 is typically prescribed as an adjunct therapy to conventional bronchodilators and anti-inflammatory drugs to optimize respiratory status and improve patient quality of life. The capsule formulation ensures convenient oral administration with good bioavailability. Dosage and duration of treatment should be individualized based on the severity of the condition and patient response, under medical supervision. Commonly reported side effects are mild and may include gastrointestinal discomfort, headache, or dizziness. Patients with hypersensitivity to methylxanthines or related compounds should avoid this medication. Xanphyl 100 Capsule is contraindicated in patients with severe cardiac arrhythmias or uncontrolled hypertension. Regular monitoring and adherence to prescribed dosage are essential to maximize therapeutic benefits and minimize adverse effects.